• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[On the importance of multidrug-resistant strains of pathogenic microorganisms in ophthalmic practice].

作者信息

Galeeva G Z, Samoylov A N, Rascheskov A Yu

机构信息

Kazan State Medical University, 49 Butlerova St., Kazan, Republic of Tatarstan, Russian Federation, 420012; Children's Republican Clinical Hospital of Ministry of Health of the Republic of Tatarstan, 140 Orenburgskiy tract, Kazan, Republic of Tatarstan, Russian Federation, 420138.

Kazan State Medical University, 49 Butlerova St., Kazan, Republic of Tatarstan, Russian Federation, 420012.

出版信息

Vestn Oftalmol. 2015 Mar-Apr;131(2):110-114. doi: 10.17116/oftalma20151312110-114.

DOI:10.17116/oftalma20151312110-114
PMID:26080593
Abstract

This is a review of epidemiological, microbiological and ophthalmological publications on the importance of multidrug-resistant bacterial strains in medical, particularly ophthalmological, care. Current state of pharmaceutical market and wide variety of generics confuses doctor's (including ophthalmologist's) sense of decision-making on the optimum antibiotic for the treatment of purulent inflammation. Indiscriminate use of antibiotics contributes to multiple drug resistance in bacteria. The world returns to the pre-antibiotic era, in which there was no treatment for severe infectious and inflammatory diseases. The most dangerous multiresistant strains known to medical science and their role in etiology of inflammatory eye diseases are listed in the article. Since neonatal conjunctivitis and postoperative endophthalmitis are the most common ocular inflammatory diseases caused by nosocomial multiresistant bacteria, their etiological classification is also described. Emergence of antibiotic resistance to most frequently used ophthalmic agents and prevention strategies are discussed.

摘要

相似文献

1
[On the importance of multidrug-resistant strains of pathogenic microorganisms in ophthalmic practice].
Vestn Oftalmol. 2015 Mar-Apr;131(2):110-114. doi: 10.17116/oftalma20151312110-114.
2
Antibiotic resistance in ocular bacterial pathogens.眼部细菌病原体中的抗生素耐药性。
Indian J Med Microbiol. 2011 Jul-Sep;29(3):218-22. doi: 10.4103/0255-0857.83903.
3
Neonatal infections due to multi-resistant strains: Epidemiology, current treatment, emerging therapeutic approaches and prevention.多重耐药菌株引起的新生儿感染:流行病学、当前治疗方法、新兴治疗手段及预防
Clin Chim Acta. 2015 Dec 7;451(Pt A):71-7. doi: 10.1016/j.cca.2015.02.038. Epub 2015 Mar 4.
4
Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones.眼感染中新兴的抗生素耐药性和氟喹诺酮类药物的作用。
J Cataract Refract Surg. 2010 Sep;36(9):1588-98. doi: 10.1016/j.jcrs.2010.06.028.
5
Clinical and microbiologic review of culture-proven endophthalmitis caused by multidrug-resistant bacteria in patients seen at a tertiary eye care center in southern India.印度南部一家三级眼科中心所见耐多药细菌引起的内眼感染的临床和微生物学回顾。
Retina. 2011 Oct;31(9):1806-11. doi: 10.1097/IAE.0b013e31820f4b9d.
6
Topical antibiotic therapy in eye infections - myths and certainties in the era of bacterial resistance to antibiotics.眼部感染的局部抗生素治疗——抗生素耐药时代的误区与定论。
Rom J Ophthalmol. 2020 Jul-Sep;64(3):245-260.
7
Infectious disease: changing antibiotic susceptibility.传染病:不断变化的抗生素敏感性。
Ophthalmol Clin North Am. 2003 Mar;16(1):1-9. doi: 10.1016/s0896-1549(02)00061-5.
8
Antibiotic susceptibilities of bacteria isolated from ophthalmic specimens between 1984 and 2005 in Zurich, Switzerland.
Klin Monbl Augenheilkd. 2007 Apr;224(4):240-3. doi: 10.1055/s-2007-962836.
9
Besifloxacin in the management of bacterial infections of the ocular surface.贝西沙星用于眼部细菌性感染的治疗
Can J Ophthalmol. 2015 Jun;50(3):184-91. doi: 10.1016/j.jcjo.2014.12.013.
10
Overview of the potency of moxifloxacin ophthalmic solution 0.5% (VIGAMOX).0.5%莫西沙星滴眼液(维加莫克斯)药效概述。
Surv Ophthalmol. 2005 Nov;50 Suppl 1:S7-15. doi: 10.1016/j.survophthal.2005.05.002.